CLIA: 39D2085645
New York State has a separate and unique regulatory approval process for laboratory diagnostic testing. PeriRx is currently in the application process with our SaliMark™ OSCC test and is vigorously committed to pursuing this application approval.
Oral Cancer
Commentary on: Does screening for disease save lives in asymptomatic adults? Systematic review of 5 meta-analyses and randomized trials
By Drs. Squib and Ioannidis
Prevalidation of Salivary Biomarkers for Oral Cancer Detection
By David Elashoff, Hui Zhou, Jean Reiss, Jianghua Wang, Hua Xiao, Bradley Henson, Shen Hu,Martha Arellano, Uttam Sinha, Anh Le, Diana Messadi, Marilene Wang, Vishad Nabili, Mark Lingen, Darly Morris, Timothy Randolph, Ziding Feng, David Akin, Dragana A. Kastratovic, David Chia, Elliot Abemayor, and David T.W. Wong\
Oral Squamous Cell Carcinoma Detection by Salivary Biomarkers in a Serbian Population
By Ole Brinkmanna, Dragana A. Kastratovic, Milovan V. Dimitrijevic, Vitomir S. Konstantinovic, Drago B. Jelovac, Jadranka Antic, Vladimir S. Nesic, Srdjan Z. Markovic, Zeljko R. Martinovic, David Akina, Nadine Spielmanna, Hui Zhoua, David T. Wong
Salivary Proteomics for Oral Cancer Biomarker Discovery
By ShenHu, Martha Arellano, Pinmanee Boontheung, Jianghua Wang, Hui Zhou, Jiang Jiang, David Elashoff, Roger Wei, Joseph A. Loo, and David T. Wong
Salivary Transcriptome Diagnostics for Oral Cancer Detection
By Yang Li, Maie A. R. St. John, Xiaofeng Zhou, Yong Kim, Uttam Sinha, Richard C.K. Jordan, David Eisele, Elliot Abemayor, David Elashoff, No-Hee Park, and David T. Wong